VIM
PFE icon

Vinva Investment Management’s Pfizer PFE Stock Holding History

Vinva Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.4M Buy
510,661
+82,562
+19% +$2.16M 0.08% 194
2026
Q1 		$11.9M Buy
428,099
+22,628
+6% +$602K 0.15% 158
2025
Q4 		$10.1M Sell
405,471
-72,703
-15% -$1.83M 0.13% 159
2025
Q3 		$11.4M Buy
478,174
+87,685
+22% +$2.16M 0.22% 116
2025
Q2 		$9.45M Buy
390,489
+122,959
+46% +$2.87M 0.25% 107
2025
Q1 		$6.74M Sell
267,530
-9,493
-3% -$248K 0.27% 96
2024
Q4 		$7.32M Buy
277,023
+83,558
+43% +$2.27M 0.28% 79
2024
Q3 		$5.63M Buy
193,465
+146,564
+312% +$4.28M 0.24% 107
2024
Q2 		$1.3M Buy
46,901
+7,122
+18% +$196K 0.07% 260
2024
Q1 		$1.1M Sell
39,779
-61,684
-61% -$1.71M 0.06% 280
2023
Q4 		$2.92M Sell
101,463
-18,965
-16% -$573K 0.2% 127
2023
Q3 		$3.86M Sell
120,428
-24,218
-17% -$856K 0.36% 67
2023
Q2 		$5.22M Sell
144,646
-14,260
-9% -$555K 0.45% 49
2023
Q1 		$6.42M Buy
+158,906
New +$6.86M 0.54% 45

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vinva Investment Management's PFE Position: Q2 2026 in Review

Vinva Investment Management increased its Pfizer (PFE) stake by 19% in Q2 2026, buying an estimated $2.16M and bringing the position to 510,661 shares worth $12.4M. The position accounts for 0.08% of the portfolio, ranked #194.

Vinva Investment Management first reported a position in PFE in Q1 2023 and has held it in 14 quarters since. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Vinva Investment Management held 510,661 shares of Pfizer worth $12.4M as of Q2 2026.
  • Vinva Investment Management bought 82,562 Pfizer shares in Q2 2026, an estimated $2.16M.
  • Pfizer made up 0.08% of Vinva Investment Management's portfolio in Q2 2026, its #194 holding.
  • Vinva Investment Management first reported a position in Pfizer in Q1 2023 and has held it in 14 quarters since.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Vinva Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.